GENERAL COMMENTS
Excellent use of data linkage to address an important question.
Suggestions to consider that might improve this paper: 1] Would all or the vast majority of infants with an admission diagnosis of 'clinical bronchiolitis' have been tested for RSV? Some centres do testing and once the RSV season starts assume that all cases are RSV. Could this be clarified so that the reader understands whether this is definitely a population study. 2] The study patients were born up until end of Dec 2010. This seems also to be when the study follow up period ended -also at end of Dec 2010. (LINE 124) . Later in the analysis the age at asthma diagnosis was grouped at age of 1st diagnosis: 2-3 y, 3-5 y, 5-7y, > 7 y ---the children born between 2009/2010 therefore would not be entered or identified as having asthma. This needs clarified. The outcome was age of 1st asthma attack. The Cox model for survival study takes into account those that are censored by not having had an attack at end of Dec 2010 according to their age on this date ---Given this, I'm just not sure of the logic of then subdividing the children by the age when they had their 1st asthma attack. 2015) . Considering this, in my opinion, the authors should explain better and concentrate in the differences in between their 3 sub-groups of children. This is a unique and important research question which would increase the added value from the manuscript. Also using the high risk sub-groups results to expand the clinical implications of the study.
• The main exposure variable in the study was a coded episode of RSV but there are studies showing that it is not so easy to identify the virus during a clinical episode of lower respiratory infection. I question whether the "coded RSV" really corresponded to RSV infections or could had been false positive and sometimes more likely another wheezing episode from a "chronic wheezing baby".
• The outcome variable is described as "first episode of asthma hospitalization" but the authors also recognize in the discussion that you can hardly declare that a wheezing child under the 4th year of age has asthma. It would be fair and more appropriated to describe the outcome as "first episode of severe wheeze leading to hospitalization" to avoid misleading interpretation of the findings.
• There were important confounders included in the analysis and as discussed by the authors I indeed miss the information regarding family diseases (maternal atopy, maternal asthma) but also information regarding current exposition to second-hand smoking, exposition to allergens, environmental (possible protective effect from farm environment) and possible use of medication for chronic/persistent wheeze previous to the so called "asthma" hospitalization. Without analyzing the listed factors as potential modifiers for the history of the disease I do not dare to make such strong conclusions about the role of RSV.
• The authors should be more modest while discussing their findings. This was a database retrospective analysis study and therefore the "chicken and the egg" paradox cannot be solved. Whether the RSV increases the risk of asthma in the future or because of other predisposition factors the child has an increased risk of severe viral infections and asthma cannot be clarified with this study design.
• Minor comment: table 1-the way it is written in the table "n(% within RSV group)"makes the reading very confusing. It would make more clear to write "n(%n)" Suggestions to consider that might improve this paper: 1] Would all or the vast majority of infants with an admission diagnosis of 'clinical bronchiolitis' have been tested for RSV? Some centres do testing and once the RSV season starts assume that all cases are RSV. Could this be clarified so that the reader understands whether this is definitely a population study.
Response: We thank the reviewer for this important comment. We agree that it is unlikely that all clinical bronchiolitis was caused by RSV. In an attempt to address this in our analysis, we only included those coded as unspecified bronchiolitis that were identified during the RSV season. In addition, we undertook a sensitivity analysis where we excluded those with unspecified bronchiolitis and only retained those with a respiratory hospitalization that had an RSV associated code (please see supplementary file for Editor only); the results did not change. We have also clarified this issue in the limitation section addressing the possible errors with coding (line 299-305).
2] The study patients were born up until end of Dec 2010. This seems also to be when the study follow up period ended -also at end of Dec 2010. (LINE 124) . Later in the analysis the age at asthma diagnosis was grouped at age of 1st diagnosis: 2-3 y, 3-5 y, 5-7y, > 7 y ---the children born between 2009/2010 therefore would not be entered or identified as having asthma. This needs clarified. The outcome was age of 1st asthma attack. The Cox model for survival study takes into account those that are censored by not having had an attack at end of Dec 2010 according to their age on this date ---Given this, I'm just not sure of the logic of then subdividing the children by the age when they had their 1st asthma attack.
Response: The reviewer is correct in pointing out that the "traditional" Cox model takes into account first episode and censors those that did not experience the event. However, in our analysis the hazard for first asthma hospitalization was not constant over time which violates the basic assumption for conducting the traditional Cox survival model. To account for this we performed an extended Cox model with time varying covariate which was the age at first asthma hospitalization. The age variable used in the model is the interaction between RSV risk (at baseline) and time broken into the 4 groups, which therefore corresponds to age at first asthma hospitalization. The data set was converted to the so called "stop -start" format which is one of the standard ways of implementing time-dependent covariates in the Cox model.
